Last reviewed · How we verify
modified Peritoneal Equilibration test
At a glance
| Generic name | modified Peritoneal Equilibration test |
|---|---|
| Sponsor | CHU de Reims |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Proof of Concept of Adapted PD in Children (PC-AAPD) (NA)
- Hydratation Status at Initiation of Peritoneal Dialysis: Study of the Role of Peritoneal Permeability (NA)
- Peritoneal Ultrafiltration to Treat Congestive Heart Failure
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- modified Peritoneal Equilibration test CI brief — competitive landscape report
- modified Peritoneal Equilibration test updates RSS · CI watch RSS
- CHU de Reims portfolio CI